71%
Finnrick rating
#4 of 40 Melanotan II vendors
4 of 4 classifiable tests passed
natural 100%
methodology · Purity focus
Finnrick analysis · Melanotan II

Eternal Peptides' Melanotan II shows a low-concern purity profile under this methodology, with identity passes and purity at/above 99.5% across labs. The caveat is lot breadth: results cluster on one batch, and later fills ran about +19%.

methodology →
vendor intelligence report
Vendor Intelligence Report: Eternal Peptides

NY filings, trademark records and the terms page tie Eternal Peptides to Cenvira LLC and named applicants, while the domain timeline leaves a launch-channel gap. The report also maps coded GLP products, restored card rails, exposed COA-page controls and promo-code activity.

24 pages4 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Retatrutide
$10.00
76%
5
2
Melanotan IIselected
$4.00
71%
4
3
Tirzepatide
$11.00
70%
5
4
Semaglutide
$11.00
54%
4
5
BPC-157
$6.50
38%
9
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%8 May 2025: 54%8 May 2025: 59%21 May 2025: 67%21 May 2025: 72%9 Aug 2026: current 71%54%71%May 25Aug 26
Showing Melanotan II tests only
Eternal Peptides Melanotan II test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
21 May 2025Pass
Tested
lab nameView COA
21 May 2025Pass
Tested
lab nameView COA
8 May 2025Pass
Tested
lab nameView COA
8 May 2025Pass
Tested
lab nameView COA

About Eternal Peptides test results from Finnrick

Eternal Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 5 peptides and 27 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Eternal Peptides peptides in this dataset are Melanotan II (4 tests) and Semaglutide (4 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 27 recent tests.

Corrections
No corrections.